INSTITUTION'S PROFILE
Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Publications (8)
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication date: 2024
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication Year: 2024
NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members.
Journal: PloS one
Publication date: 2014
Journal: PloS one
Publication Year: 2014
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication date: 2017
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication Year: 2017
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
Journal: PloS one
Publication date: 2017
Journal: PloS one
Publication Year: 2017
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.
Journal: AIDS and behavior
Publication date: 2018
Journal: AIDS and behavior
Publication Year: 2018
The Role of Religious Service Attendance, Psychosocial and Behavioral Determinants of Antiretroviral Therapy (ART) Adherence: Results from HPTN 063 Cohort Study.
Journal: AIDS and behavior
Publication date: 2019
Journal: AIDS and behavior
Publication Year: 2019
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.
Journal: EClinicalMedicine
Publication date:
Journal: EClinicalMedicine
Publication Year:
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Journal: The lancet. HIV
Publication date: 2023
Journal: The lancet. HIV
Publication Year: 2023